These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29526312)

  • 1. Guillain-Barré syndrome and hyponatraemia.
    Ternero Vega JE; León RG; Delgado DA; Baturone MO
    Neurologia (Engl Ed); 2020 May; 35(4):282-284. PubMed ID: 29526312
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolvaptan efficacy and drug-drug interactions.
    Piccica M; Basile G; Bartalesi F; Parenti G; Farese A; Buci L; Corti G; Bartoloni A; Peri A
    Minerva Endocrinol; 2020 Sep; 45(3):264-265. PubMed ID: 32272825
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with Tolvaptan outpatient use. Cost and effectiveness in 9 cases.
    Barajas-Galindo DE; Vidal-Casariego A; Gómez-Hoyos E; Guerra-González M
    Gac Med Mex; 2020; 156(1):78-81. PubMed ID: 32026886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyponatraemia in Guillain-Barré syndrome revisited.
    Hiew FL; Winer JB; Rajabally YA
    Acta Neurol Scand; 2016 Apr; 133(4):295-301. PubMed ID: 26184092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
    Bilgetekin I; Erturk I; Basal FB; Karacin C; Karadurmus N; Oksuzoglu B; Demirci U
    Int Urol Nephrol; 2021 Feb; 53(2):301-307. PubMed ID: 32869173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma.
    Gürbüz F; Taştan M; Turan İ; Yüksel B
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):202-206. PubMed ID: 30257818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
    Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
    CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis in cancer patients with hyponatremia: effectiveness of tolvaptan treatment.
    Kawada T
    Int Urol Nephrol; 2022 Oct; 54(10):2759. PubMed ID: 35347558
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyponatraemic encephalopathy as the initial presentation of Guillain-Barre syndrome.
    Ramanathan M
    Med J Malaysia; 2008 Dec; 63(5):426-7. PubMed ID: 19803310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral tolvaptan for severe edema and hyponatremia in a patient with refractory nephrotic syndrome.
    Saimiya M; Kaku Y; Nishimura M
    CEN Case Rep; 2021 Nov; 10(4):523-526. PubMed ID: 33904139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
    BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
    Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
    Chatzimavridou-Grigoriadou V; Al-Othman S; Brabant G; Kyriacou A; King J; Blackhall F; Trainer PJ; Higham CE
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4766-e4775. PubMed ID: 33693944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyponatraemia in elderly patient - significance, clarification and therapy].
    Gosch M
    Dtsch Med Wochenschr; 2022 Mar; 147(6):301-305. PubMed ID: 35291034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
    Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
    Harbeck B; Lindner U; Haas CS
    Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of hyponatraemia in the older patient.
    Woodward M; Gonski P; Grossmann M; Obeid J; Scholes R; Topliss DJ
    Intern Med J; 2018 Jan; 48 Suppl 1():5-12. PubMed ID: 29318728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
    Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A
    Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of tolvaptan in patients with hyponatremia due to heart failure: initial experience.
    Rodríguez-de Muñoz YM; Sánchez-Lázaro IJ; Almenar-Bonet L; Martínez-Dolz L; Rodríguez-Serrano M; Salvador-Sanz A
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):319-21. PubMed ID: 24775629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.